Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2001-7-9
pubmed:abstractText
The endometrium is a tissue unique for its cyclic destruction and rapid regeneration of blood vessels. Angiogenesis, indispensable for the regeneration process, provides a richly vascularized, receptive endometrium fundamental for implantation, placentation, and embryogenesis. Human endometrial microvascular endothelial cells (hEMVEC) were isolated to better understand the properties and angiogenic behavior of these cells. Unlike human foreskin microvascular endothelial cells (hFMVEC), which proliferated better upon stimulation by basic fibroblast growth factor, hEMVEC were much more sensitive to vascular endothelial growth factor A (VEGF-A) stimulation, probably due to enhanced VEGF receptor 2 expression. In addition, hEMVEC displayed an enhanced expression of the urokinase-type plasminogen activator (u-PA) compared with hFMVEC. No differences were found in tissue-type PA, PA inhibitor-1, and u-PA receptor expression. The high expression of u-PA by hEMVEC was also found in tissue sections. hEMVEC formed capillary-like structures when cultured in 20% human serum on top of three-dimensional fibrin matrices, and VEGF-A or basic fibroblast growth factor increased this tube formation. This is in contrast with hFMVEC, which formed tubes only after simultaneous stimulation by a growth factor and tumor necrosis factor-alpha. The high basal level of u-PA contributes to and may explain the higher angiogenic properties of hEMVEC (in vitro).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/PLAUR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activators, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Urokinase Plasminogen..., http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-972X
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3359-67
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11443212-Capillaries, pubmed-meshheading:11443212-Cell Division, pubmed-meshheading:11443212-Cell Separation, pubmed-meshheading:11443212-Cells, Cultured, pubmed-meshheading:11443212-Endometrium, pubmed-meshheading:11443212-Endothelial Growth Factors, pubmed-meshheading:11443212-Endothelium, Vascular, pubmed-meshheading:11443212-Female, pubmed-meshheading:11443212-Fibroblast Growth Factor 2, pubmed-meshheading:11443212-Humans, pubmed-meshheading:11443212-Menstrual Cycle, pubmed-meshheading:11443212-Neovascularization, Physiologic, pubmed-meshheading:11443212-Plasminogen Activator Inhibitor 1, pubmed-meshheading:11443212-Plasminogen Activators, pubmed-meshheading:11443212-Receptors, Cell Surface, pubmed-meshheading:11443212-Receptors, Urokinase Plasminogen Activator, pubmed-meshheading:11443212-Tissue Plasminogen Activator, pubmed-meshheading:11443212-Tumor Necrosis Factor-alpha, pubmed-meshheading:11443212-Urokinase-Type Plasminogen Activator, pubmed-meshheading:11443212-Vascular Endothelial Growth Factor A
pubmed:year
2001
pubmed:articleTitle
Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium.
pubmed:affiliation
Gaubius Laboratory TNO-PG, 2333 CK Leiden, The Netherlands. p.koolwijk@pg.tno.nl
pubmed:publicationType
Journal Article